PERIPHERAL ARTERIAL OCCLUSIVE DISEASE side effect
What is PERIPHERAL ARTERIAL OCCLUSIVE DISEASE ?Drugs associated with PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
AMEVIVE AVONEX CELEBREX CILOSTAZOL CRESTOR ERBITUX GEMCITABINE HUMIRA IMPLANON PANITUMUMAB PLAVIX SEROQUEL TESTOSTERONEPERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Gemcitabine Side Effects Report #5618822-8
Physician from BRAZIL reported GEMCITABINE problem on Jan 28, 2008. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: peripheral arterial occlusive disease, . GEMCITABINE dosage: unknown. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Humira Side Effects Report #5623090-7
HUMIRA problem was reported by a Consumer or non-health professional from GREECE on Feb 05, 2008. Male patient, weighting 143.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: peripheral arterial occlusive disease, . HUMIRA dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, LEKOVIT CA, TENORETIC. Patient was hospitalized. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Humira Side Effects Report #5635074-3
Consumer or non-health professional from GREECE reported HUMIRA problem on Feb 13, 2008. Male patient, weighting 143.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: peripheral arterial occlusive disease, . HUMIRA dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, LEKOVIT CA, TENORETIC. Patient was hospitalized. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Humira Side Effects Report #5601801-4
HUMIRA problem was reported by a Consumer or non-health professional from GREECE on Jan 18, 2008. Male patient, weighting 143.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: peripheral arterial occlusive disease, . HUMIRA dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, LEKOVIT CA, TENORETIC. Patient was hospitalized. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Avonex Side Effects Report #5450578-4
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Sept 04, 2007. Female patient, 49 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: peripheral arterial occlusive disease, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Crestor Side Effects Report #5465950-6
CRESTOR problem was reported by a Physician from JAPAN on Sept 13, 2007. Male patient, weighting 125.7 lb, was diagnosed with hyperlipidaemia, benign prostatic hyperplasia, dysuria, osteoporosis and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: peripheral arterial occlusive disease, rhabdomyolysis, . CRESTOR dosage: 2.5 MG ALTERNATE DAY DOSE. During the same period patient was treated with UBRETID, FLIVAS, PROSTAL, ACTONEL, CALFINA. Patient was hospitalized. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Cilostazol Side Effects Report #5594578-2
Consumer or non-health professional from GERMANY reported CILOSTAZOL problem on Jan 02, 2008. Female patient, 67 years of age, was diagnosed with intermittent claudication and was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: condition aggravated, peripheral arterial occlusive disease, . CILOSTAZOL dosage: 200 MG ORAL. During the same period patient was treated with ASPIRIN, SIMVASTATIN, CLOPIDOGREL BISULPHATE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Testosterone Side Effects Report #5597974-2
TESTOSTERONE problem was reported by a Physician from GERMANY on Jan 02, 2008. Male patient, 30 years of age, was diagnosed with klinefelter's syndrome and was treated with TESTOSTERONE. After drug was administered, patient experienced the following problems/side effects: hypercoagulation, peripheral arterial occlusive disease, thrombosis, . TESTOSTERONE dosage: unknown. Patient was hospitalized. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Plavix Side Effects Report #5621126-0
Consumer or non-health professional from UNITED STATES reported PLAVIX problem on Feb 02, 2007. Female patient, 91 years of age, was diagnosed with prophylaxis and was treated with PLAVIX. After drug was administered, patient experienced the following problems/side effects: pain in extremity, peripheral arterial occlusive disease, stent occlusion, . PLAVIX dosage: 75 MG QD - ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, ATENOLOL, HYDROCHLOROTHIAZIDE, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Implanon Side Effects Report #5577788-X
IMPLANON problem was reported by a Consumer or non-health professional from SWITZERLAND on Dec 11, 2007. Female patient, 35 years of age, was diagnosed with contraception and was treated with IMPLANON. After drug was administered, patient experienced the following problems/side effects: blood triglycerides decreased, peripheral arterial occlusive disease, . IMPLANON dosage: unknown. During the same period patient was treated with PICOSULPHATE, MIRTAZAPINE, LORAZEPAM. Patient was hospitalized. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Seroquel Side Effects Report #5460112-0
Physician from UNITED STATES reported SEROQUEL problem on Aug 02, 2007. Female patient, weighting 164.2 lb, was diagnosed with schizophrenia, bipolar disorder, depression and was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, peripheral arterial occlusive disease, . SEROQUEL dosage: unknown. During the same period patient was treated with RISPERDAL, ABILIFY. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Celebrex Side Effects Report #5441060-9
CELEBREX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 20, 2007. Female patient was diagnosed with arthritis and was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, peripheral arterial occlusive disease, . CELEBREX dosage: unknown. Patient was hospitalized. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Amevive Side Effects Report #5389033-9
Physician from UNITED STATES reported AMEVIVE problem on July 02, 2007. Female patient, 76 years of age, weighting 160.1 lb, was diagnosed with psoriasis and was treated with AMEVIVE. After drug was administered, patient experienced the following problems/side effects: arterial insufficiency, peripheral arterial occlusive disease, pneumonia, pulmonary oedema, . AMEVIVE dosage: unknown. During the same period patient was treated with GLUCOPHAGE, HUMULIN, LASIX, SPIRONOLACTONE, TOPROL, PLAVIX, FOLIC ACID, PROTONIX. Patient was hospitalized. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Amevive Side Effects Report #5389033-9
AMEVIVE problem was reported by a Physician from UNITED STATES on July 02, 2007. Female patient, 76 years of age, weighting 160.1 lb, was diagnosed with psoriasis and was treated with AMEVIVE. After drug was administered, patient experienced the following problems/side effects: arterial insufficiency, peripheral arterial occlusive disease, pneumonia, pulmonary oedema, . AMEVIVE dosage: unknown. During the same period patient was treated with GLUCOPHAGE, HUMULIN, LASIX, SPIRONOLACTONE, TOPROL, PLAVIX, FOLIC ACID, PROTONIX. Patient was hospitalized. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Plavix Side Effects Report #5621239-3
Consumer or non-health professional from UNITED STATES reported PLAVIX problem on Apr 19, 2007. Male patient, 75 years of age, weighting 245.0 lb, was diagnosed with stent placement and was treated with PLAVIX. After drug was administered, patient experienced the following problems/side effects: arthritis, pain in extremity, peripheral arterial occlusive disease, post procedural haemorrhage, . PLAVIX dosage: 75 MG QD - ORAL. During the same period patient was treated with OMEPRAZOLE, LISINOPRIL, ATORVASTATIN CALCIUM, VERAPAMIL HYDROCHLORIDE, ALLOPURINOL, ASPIRIN, HYDROCHLOROTHIAZIDE, CELECOXIB. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Erbitux Side Effects Report #5419712-6
ERBITUX problem was reported by a Physician from GERMANY on Aug 13, 2007. Male patient, 71 years of age, was diagnosed with laryngeal cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, escherichia sepsis, peripheral arterial occlusive disease, . ERBITUX dosage: unknown. During the same period patient was treated with MARCUMAR, PARACETAMOL, NIFEDIPINE, SIMVASTATIN, AMIODARONE. Patient was hospitalized and became disabled. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Panitumumab Side Effects Report #5386520-4
Physician from POLAND reported PANITUMUMAB problem on July 03, 2007. Female patient was diagnosed with colorectal cancer and was treated with PANITUMUMAB. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, iliac artery embolism, peripheral arterial occlusive disease, . PANITUMUMAB dosage: unknown. Patient was hospitalized. Patient recovered.
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE : Panitumumab Side Effects Report #5386520-4
PANITUMUMAB problem was reported by a Physician from POLAND on July 03, 2007. Female patient was diagnosed with colorectal cancer and was treated with PANITUMUMAB. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, iliac artery embolism, peripheral arterial occlusive disease, . PANITUMUMAB dosage: unknown. Patient was hospitalized. Patient recovered.